Suppr超能文献

甲状腺相关眼病眼眶组织的蛋白质组学研究。

Proteomics of Orbital Tissue in Thyroid-Associated Orbitopathy.

机构信息

Molecular Thyroid Research Laboratory (N.M., G.J.K.), Department of Medicine I, Experimental Ophthalmology (N.M., F.H.G., D.W.), and Department of Ophthalmology (F.H.G., K.A.P., S.P., N.P.), Johannes Gutenberg University Medical Center (J.G.U.), Mainz 55101, Germany; Departments of Endocrinology (M.L., T.P., B.S.) and Plastic Surgery (H.B.), Lund University, 221 00 Lund, Sweden; and Skåne University Hospital, 214 28 Malmö, Sweden.

出版信息

J Clin Endocrinol Metab. 2015 Dec;100(12):E1523-30. doi: 10.1210/jc.2015-2976. Epub 2015 Oct 9.

Abstract

CONTEXT

A potentially altered protein expression profile in orbital tissue from patients with thyroid-associated orbitopathy (TAO) is suspected.

OBJECTIVE

To detect for the first time changes in proteomic patterns of orbital connective tissue in TAO and compare these with control tissue using mass spectrometry.

DESIGN

Proteomics cross-sectional, comparative study.

SETTING

Two academic endocrine institutions.

SAMPLES

A total of 64 orbital and peripheral adipose tissue samples were collected from 39 patients with TAO and 25 control subjects.

METHODS

Samples were analyzed and identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry technology.

MAIN OUTCOME MEASURES

Mean intensity values of all identified peptides per protein.

RESULTS

Thirty-one proteins were identified, of which 16 differentiated between controls and patients with TAO. Different protein patterns between orbital and peripheral adipose tissue were observed. Compared to controls, 10 proteins were markedly up-regulated (≥ 2-fold) in the orbital tissue of untreated patients: beta IV spectrin (6.2-fold), GTP binding G protein 2 (5.6-fold), POTE ankyrin domain family member F (5.4-fold), xylulokinase (4.1-fold), kinesin family member 1A and lipocalin 1 (both 3.6-fold), semicarbazide-sensitive metalloproteinase amine oxidase 3 and polymerase I transcript release factor (both 3.4-fold), cell-cycle protein elongin A binding protein 1 (3.3-fold), annexin A2 and cavin (both 3-fold), protein pointing to cell proliferation histone H4 (2.8-fold), and ADAM metallopeptidase with thrombospondin type 1 motif 14 (2.7-fold). The highest protein up-regulations were noted in the orbital tissue of medically untreated patients. Steroid therapy markedly reduced up-regulation of these proteins, foremost in nonsmokers.

CONCLUSIONS

Proteins involved in tissue inflammation, adipose tissue differentiation, lipid metabolism, and tissue remodeling were up-regulated in orbital tissue of untreated patients with TAO. Steroids decreased the expression of these proteins, whereas smoking attenuated such effect.

摘要

背景

怀疑甲状腺相关眼病(TAO)患者眼眶组织中存在潜在改变的蛋白质表达谱。

目的

首次使用质谱法检测 TAO 眼眶结缔组织的蛋白质组学图谱变化,并与对照组织进行比较。

设计

蛋白质组学的横断面、对比研究。

设置

两家学术内分泌机构。

样本

共采集 39 例 TAO 患者和 25 例对照患者的 64 例眼眶和外周脂肪组织样本。

方法

使用基质辅助激光解吸/电离飞行时间质谱技术对样本进行分析和鉴定。

主要观察指标

每个蛋白质的所有鉴定肽的平均强度值。

结果

鉴定出 31 种蛋白质,其中 16 种可区分对照和 TAO 患者。观察到眼眶和外周脂肪组织之间存在不同的蛋白质模式。与对照组相比,未经治疗的患者眼眶组织中有 10 种蛋白质明显上调(≥2 倍):β IV spectrin(6.2 倍)、GTP 结合 G 蛋白 2(5.6 倍)、POTE ankyrin 结构域家族成员 F(5.4 倍)、木酮糖激酶(4.1 倍)、亲脂素 1 和肌球蛋白家族成员 1A(均 3.6 倍)、半乳糖胺敏感型金属蛋白酶胺氧化酶 3 和聚合酶 I 转录释放因子(均 3.4 倍)、细胞周期蛋白 elongin A 结合蛋白 1(3.3 倍)、膜联蛋白 A2 和 cavin(均 3 倍)、指向细胞增殖的组蛋白 H4(2.8 倍)和 ADAM 金属肽酶与血栓反应蛋白 1 型基序 14(2.7 倍)。这些蛋白质的上调在未经治疗的患者的眼眶组织中最为明显。类固醇治疗显著降低了这些蛋白质的上调,尤其是在不吸烟者中。

结论

在未经治疗的 TAO 患者的眼眶组织中,涉及组织炎症、脂肪组织分化、脂质代谢和组织重塑的蛋白质被上调。类固醇降低了这些蛋白质的表达,而吸烟则减弱了这种作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验